quote:People shouldn't have to wait for approval. If they know the risks and want to give it a shot, they should be able to. Isn't that what the drug trials are basically, but with a limited pool of people?
See one of my other posts where UK took an extra 2 years to apprive a cancer drug and an estimated 5,000 women died.
They may have the research but, they don't use them because they are expensive or the red tape is so slow. See one of my other posts where UK took an extra 2 years to apprive a cancer drug and an estimated 5,000 women died.
There probably would be a hit but the form it would take? I couldn't say. A friend works for GSK's main site here in Canada and they work on some pretty amazing stuff, but I don't know how much of that is subsidized by the Canadian or Ontario system and how much is supported by the UK or other places, more privately. It would be a bit of a tangle to work out I'd imagine. But I don't think we'd be entering a medical Dark Ages
Ninety five percent of the new drugs coming on the market are developed for sale in the United States. They are paid for by American consumers, while other countries, such as Canada, Germany and France, free ride at our expense.
The United States is the last major country that allows the market to set prices high enough to compensate pharmaceutical companies for their R&D investments. Obama Care will increasingly control pharmaceutical prices as costs rise and federal and state funds fall short. Major pharmaceutical advances will stop (How well will government labs work?), and the rest of the world will lose along with Americans.